Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1624569

This article is part of the Research TopicReviews in Ethnopharmacology: 2025View all 24 articles

Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review

Provisionally accepted
  • 1First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China
  • 2Heilongjiang University of Chinese Medicine, Harbin, China
  • 3Shaoxing Maternal and Child Health Hospital, Shaoxing, China

The final, formatted version of the article will be published soon.

Endometriosis (EMs) is a prevalent benign gynecological disorder characterized by dysmenorrhea and infertility, significantly impacting women's health and quality of life. Currently, the pathogenesis of EMs remains incompletely elucidated. There are various side effects of drug treatment, while surgical interventions involve a certain degree of tissue trauma. Therefore, novel therapeutic drugs and clinical strategies should be developed. Apoptosis, a programmed cell death pathway, maintains tissue homeostasis, and its dysregulation is linked to various diseases and pathological complexities.Accumulating evidence suggests that abnormal apoptosis is intricately linked to the development and progression of EMs and that targeted promotion of cell apoptosis may contribute to the prevention and treatment of EMs. Natural metabolites, with their biological properties such as multipathway and multitarget effects, exhibit unique advantages in treating EMs, possibly by regulating apoptosis. This paper reviews the relationship between apoptosis and EMs. It systematically summarizes the latest progress of natural metabolites in treating EMS by regulating apoptosis, offering an innovative strategy for treating EMs.

Keywords: Natural plant metabolites, Apoptosis, Endometriosis, Clinical Translation;, Signaling Pathways

Received: 07 May 2025; Accepted: 30 Jun 2025.

Copyright: © 2025 YU, Zhu, Gao, Wang, Li and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Yang YU, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China
Shiying Li, Heilongjiang University of Chinese Medicine, Harbin, China
Ying Guo, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.